Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahmed M Elsharkawy

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Journal of Hepatology|December 13, 2006
Todralazine hepatotoxicity: a sting in the histone tailAhmed M Elsharkawy
BMJ Open Gastroenterology|October 19, 2016
Management of hepatitis C genotype 4 in the directly acting antivirals eraEmma Hathorn, Ahmed M Elsharkawy
Hepatology (Baltimore, Md.)|July 31, 2007
Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axisAhmed M Elsharkawy, Derek A Mann
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 1, 2014
Is the aerobic capacity at the time of cardiopulmonary exercise testing useful in predicting survival following liver transplantation?Rebecca Young, Nick Murphy, Ahmed M Elsharkawy
Cold Spring Harbor Perspectives in Medicine|October 2, 2019
Hepatitis C Virus Epidemiology and the Impact of Interferon-Free Hepatitis C Virus TherapyJeffrey V Lazarus, Elena Roel, Ahmed M Elsharkawy
Expert Review of Gastroenterology & Hepatology|July 5, 2022
Acute-on-chronic liver failure (ACLF) in 2022: have novel treatment paradigms already arrived?Nadir Abbas, Neil Rajoriya, Ahmed M Elsharkawy, et al.
The American Journal of Gastroenterology|January 10, 2014
The etiology of intrahepatic cholestasis of pregnancy: towards solving a monkey puzzleGwilym J Webb, Ahmed M Elsharkawy, Gideon M Hirschfield
Hepatology (Baltimore, Md.)|March 17, 2015
Is pentoxifylline still an option in severe alcoholic hepatitis?Sarah A Townsend, Ian A Rowe, Ahmed M Elsharkawy
Liver International : Official Journal of the International Association for the Study of the Liver|October 26, 2018
Leaving behind pegylated interferon-based regimens to eliminate hepatitis C as a public health threat by 2030 as set out by WHOJeffrey V Lazarus, Juan M Pericàs, Ahmed M Elsharkawy
Expert Reviews in Molecular Medicine|April 30, 2008
Wound healing and local neuroendocrine regulation in the injured liverMohammad R Ebrahimkhani, Ahmed M Elsharkawy, Derek A Mann
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Journal of Hepatology|December 13, 2006
Todralazine hepatotoxicity: a sting in the histone tailAhmed M Elsharkawy
BMJ Open Gastroenterology|October 19, 2016
Management of hepatitis C genotype 4 in the directly acting antivirals eraEmma Hathorn, Ahmed M Elsharkawy
Hepatology (Baltimore, Md.)|July 31, 2007
Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axisAhmed M Elsharkawy, Derek A Mann
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 1, 2014
Is the aerobic capacity at the time of cardiopulmonary exercise testing useful in predicting survival following liver transplantation?Rebecca Young, Nick Murphy, Ahmed M Elsharkawy
Cold Spring Harbor Perspectives in Medicine|October 2, 2019
Hepatitis C Virus Epidemiology and the Impact of Interferon-Free Hepatitis C Virus TherapyJeffrey V Lazarus, Elena Roel, Ahmed M Elsharkawy
Expert Review of Gastroenterology & Hepatology|July 5, 2022
Acute-on-chronic liver failure (ACLF) in 2022: have novel treatment paradigms already arrived?Nadir Abbas, Neil Rajoriya, Ahmed M Elsharkawy, et al.
The American Journal of Gastroenterology|January 10, 2014
The etiology of intrahepatic cholestasis of pregnancy: towards solving a monkey puzzleGwilym J Webb, Ahmed M Elsharkawy, Gideon M Hirschfield
Hepatology (Baltimore, Md.)|March 17, 2015
Is pentoxifylline still an option in severe alcoholic hepatitis?Sarah A Townsend, Ian A Rowe, Ahmed M Elsharkawy
Liver International : Official Journal of the International Association for the Study of the Liver|October 26, 2018
Leaving behind pegylated interferon-based regimens to eliminate hepatitis C as a public health threat by 2030 as set out by WHOJeffrey V Lazarus, Juan M Pericàs, Ahmed M Elsharkawy
Expert Reviews in Molecular Medicine|April 30, 2008
Wound healing and local neuroendocrine regulation in the injured liverMohammad R Ebrahimkhani, Ahmed M Elsharkawy, Derek A Mann
Pageof 6